Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 43063-458

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 43063-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 01

Chemical structure diagram of the active ingredient Lisinopril, showing its molecular composition including phenyl ring, peptide bonds, and hydration state with two water molecules.*

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 02

Chemical structure of hydrochlorothiazide, an active ingredient in Lisinopril and Hydrochlorothiazide tablets. The diagram shows the molecular arrangement with chlorine, sulfur, nitrogen, and oxygen atoms.*

FDA Label Image

43063458 Label (43063458)

Label for Lisinopril and Hydrochlorothiazide tablets 20 mg/12.5 mg, containing 90 tablets, manufactured by PD-Rx Pharmaceuticals, Inc. The label includes the NDC 43063-458-90, lot number A20F61, and expiration date 01/2022. It features warnings to keep out of reach of children and instructions to discontinue use when pregnancy is detected.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.